Portable electronic vision enhancement systems in comparison with optical magnifiers for near vision activities: an economic evaluation alongside a randomized crossover trial

Acta Ophthalmologica

Volumn 95, Issue 5, 2017, Pages e415-e423

  Bray, Nathan ^a   Brand, Andrew ^b   Taylor, John ^c   Hoare, Zoe ^b   Dickinson, Christine ^c   Edwards, Rhiannon T ^a  

^a BANGOR UNIVERSITY   (United Kingdom)

^b North Wales Organisation for Randomised Trials in Health (NWORTH) Institute of Medical and Social Care Research   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

economic evaluation; health economics; low vision aid; portable electronic vision enhancement system; visual impairment

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CROSSOVER PROCEDURE; FEMALE; HUMAN; LOW VISION MAGNIFIER; MAJOR CLINICAL STUDY; MALE; OPTICAL VISUAL AID; PORTABLE ELECTRONIC VISION ENHANCEMENT SYSTEM; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; VISUAL IMPAIRMENT; WELLBEING; COST BENEFIT ANALYSIS; DEVICES; ECONOMICS; EQUIPMENT DESIGN; IMAGE PROCESSING; MYOPIA; OPTICAL INSTRUMENTATION; PATHOPHYSIOLOGY; QUESTIONNAIRE; READING; SENSORY AID; VISION, LOW; VISUAL ACUITY; VISUALLY IMPAIRED PERSON;

AGED; COST-BENEFIT ANALYSIS; CROSS-OVER STUDIES; EQUIPMENT DESIGN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MYOPIA; OPTICAL DEVICES; QUALITY OF LIFE; READING; SENSORY AIDS; SURVEYS AND QUESTIONNAIRES; VISION, LOW; VISUAL ACUITY; VISUALLY IMPAIRED PERSONS;

EID: 85022175588     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.13255     Document Type: Article

References (29)

1. Al-Janabi H, Flynn TN & Coast J (2012): Development of a self-report measure of capability wellbeing for adults: The ICECAP-A. Qual Life Res 21: 167–176.
2. Bonsignore M, Barkow K, Jessen F & Heun R (2001): Validity of the five-item WHO Well-being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci 251(suppl): 27–31.
3. Bozzani FM, Alavi Y, Jofre-Bonet M & Kuper H (2012): A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma. BMC Ophthalmol 12: 43.
4. Briggs A, Wonderling D & Mooney C (1997): Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 6: 327–340.
5. Charlton M, Jenkins DR, Rhodes C, Martin-Smith T & Ryan B (2011): The Welsh low vision service-a summary. Optom Pract 12: 29–38.
6. Culham LE, Chabra A & Rubin GS (2004): Clinical performance of electronic, head-mounted, low vision devices. Ophthalmic Physiol Opt 24: 281–290.
7. Culham LE, Chabra A & Rubin GS (2009): Users’ subjective evaluation of electronic vision enhancement systems. Ophthalmic Physiol Opt 29: 138–149.
8. Curtis L (2011): Unit costs of health and social care 2011. Canterbury: Personal Social Services Research Unit, University of Kent. ISSN: 1368-230X. ISBN: 978-1-902671-74-1.
9. Curtis L (2014). Unit costs of health and social care 2014. Canterbury: Personal Social Services Research Unit, University of Kent. ISSN: 1368-230X. ISBN: 978-1-902671-89-5.
10. Euroqol Group (1990): EuroQoL – a new facility for the measurement of health-related quality of life. Health Policy 16: 199–208.
11. Evans JR, Fletcher AE & Wormald RPL (2007): Depression and anxiety in visually impaired older people. Ophthalmology 114: 283–288.
12. Herdman M, Gudex C, Lloyd MF, Janssen P, Kind D, Parkin D, Bonsel G & Badia X (2011): Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 20: 1727–1736.
13. van Hout B, Janssen MF, Feng YS et al. (2012): Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 15: 708–715.
14. Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, Swinburn P & Busschbach J (2013): Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 22: 1717–1727.
15. Longworth L, Yang Y, Young T et al. (2014): Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol Assess 18: 1–224.
16. Lowe B, Spitzer RL, Grafe K et al. (2004): Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 78: 131–140.
17. Massof RW (2007): An interval-scaled scoring algorithm for visual function questionnaires. Optom Vis Sci 84: 689–705.
18. McIlwaine GG, Bell JA & Dutton GN (1991): Low vision aids – is our service cost effective? Eye 5: 607–611.
19. Misajon R, Hawthorne G, Richardson J, Barton J, Peacock S, Iezzi A & Keeffe J (2005): Vision and quality of life: the development of a utility measure. Invest Ophthalmol Vis Sci 46: 4007–4015.
20. Mitchell PM, Roberts TE, Barton PM & Coast J (2015): Assessing sufficient capability; a new approach to economic evaluation. Soc Sci Med 139: 71–79.
21. Mogyorosy Z & Smith P (2005). The main methodological issues in costing health care services: a literature review. York: Centre for Health Economics, University of York.
22. National Institute for Health and Care Excellence [NICE] (2013). Guide to the methods of technology appraisal. London: National Institute for Health and Care Excellence.
23. Nollett CL, Bray N, Bunce C et al. (2016): High prevalence of untreated depression in patients accessing low-vision services. Ophthalmology 123: 440–441.
24. Peacock S, Misajon R, Iezzi A, Richardson J, Hawthorne G & Keeffe J (2008): Vision and quality of life: development of methods for the VisQoL vision-related utility instrument. Ophthalmic Epidemiol 15: 218–223.
25. Peterson RC, Wolffsohn JW, Rubinstein M & Lowe J (2003): Benefits of electronic vision enhancement systems (EVES) for the visually impaired. Am J Ophthalmol 136: 1129–1135.
26. Royal College of Nursing (2014): Pay rates 2014-15. London: Royal College of Nursing. Available at: https://www.rcn.org.uk/support/pay_and_conditions/pay_rates_2014-15. (Accessed on 3 Mar 2016).
27. Stelmack JA & Massof RW (2007): Using the VA LV VFQ-48 and LV VFQ-20 in low vision rehabilitation. Optom Vis Sci 84: 705–709.
28. Taylor J, Bambrick R, Dutton M et al. (2014): The p-EVES study design and methodology: a randomised controlled trial to compare portable electronic vision enhancement systems (p-EVES) to optical magnifiers for near vision activities in visual impairment. Ophthalmic Physiol Opt 34: 558–572.
29. Tosh J, Brazier J, Evans P & Longworth L (2012): A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health 15: 118–127.